Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles-Reference-Cited by-同舟云学术

Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles

Published:2016-05-26 Issue:10 Volume:57 Page:1599-1606
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Hostetler Eric D.,Walji Abbas M.,Zeng Zhizhen,Miller Patricia,Bennacef Idriss,Salinas Cristian,Connolly Brett,Gantert Liza,Haley Hyking,Holahan Marie,Purcell Mona,Riffel Kerry,Lohith Talakad G.,Coleman Paul,Soriano Aileen,Ogawa Aimie,Xu Serena,Zhang Xiaoping,Joshi Elizabeth,Della Rocca Joseph,Hesk David,Schenk David J.,Evelhoch Jeffrey L.

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference29 articles.

1. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study

2. Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI

3. Correlation of Alzheimer Disease Neuropathologic Changes With Cognitive Status: A Review of the Literature

4. Neocortical Neurofibrillary Tangles Correlate With Dementia Severity in Alzheimer's Disease

5. Tau Positron Emission Tomography (PET) Imaging: Past, Present, and Future

Cited by 223 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Story recall performance and AT classification via positron emission tomography: A comparison of logical memory and Craft Story 21;Journal of the Neurological Sciences;2024-09

2. Implementation and Assessment of Tau Thresholds in Non-Demented Individuals as Predictors of Cognitive Decline in Tau Imaging Studies;Journal of Alzheimer's Disease;2024-08-20

3. Radioiodinated Tau Imaging Agent III Molecular Modeling, Synthesis, and Evaluation of a New Tau Imaging Agent, [125I]ISAS in Post-Mortem Human Alzheimer’s Disease Brain;Molecules;2024-07-13

4. Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies;Nature Communications;2024-06-14

5. Biomarkers and Target-Specific Small-Molecule Drugs in Alzheimer’s Diagnostic and Therapeutic Research: From Amyloidosis to Tauopathy;Neurochemical Research;2024-06-06